SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
therapeutic 1,610 words KG: A2A 2026-03-22
kind:therapeuticsection:therapeuticsstate:published
Contents

Istradefylline (Nourianz)

💊 Therapeutic Info
NameIstradefylline (Nourianz)
SummaryIstradefylline (Nourianz) — first non-dopaminergic therapy for Parkinson's disease, adenosine A2A receptor antagonist

Knowledge Graph

Related Hypotheses (1)

Adenosine-Astrocyte Metabolic Reset
Score: 0.56

Related Analyses (3)

Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archivedBlood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived

Knowledge Graph (1 edges)

Caffeine inhibits A2A
SciDEX — scidex.ai — Dashboard | Atlas